ES2172697T3 - Metodo y composiciones para la sintesis de nucleosidos de dioxolano que tienen una configuracion beta. - Google Patents
Metodo y composiciones para la sintesis de nucleosidos de dioxolano que tienen una configuracion beta.Info
- Publication number
- ES2172697T3 ES2172697T3 ES96941539T ES96941539T ES2172697T3 ES 2172697 T3 ES2172697 T3 ES 2172697T3 ES 96941539 T ES96941539 T ES 96941539T ES 96941539 T ES96941539 T ES 96941539T ES 2172697 T3 ES2172697 T3 ES 2172697T3
- Authority
- ES
- Spain
- Prior art keywords
- compositions
- synthesis
- nucleosids
- dioxolan
- beta configuration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical compound C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 title abstract 2
- 230000015572 biosynthetic process Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 238000003786 synthesis reaction Methods 0.000 title abstract 2
- 230000013595 glycosylation Effects 0.000 abstract 1
- 238000006206 glycosylation reaction Methods 0.000 abstract 1
- 239000002777 nucleoside Substances 0.000 abstract 1
- 150000003833 nucleoside derivatives Chemical class 0.000 abstract 1
- 230000000707 stereoselective effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9525606.1A GB9525606D0 (en) | 1995-12-14 | 1995-12-14 | Method and compositions for the synthesis of dioxolane nucleosides with - configuration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2172697T3 true ES2172697T3 (es) | 2002-10-01 |
Family
ID=10785435
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES96941539T Expired - Lifetime ES2172697T3 (es) | 1995-12-14 | 1996-12-13 | Metodo y composiciones para la sintesis de nucleosidos de dioxolano que tienen una configuracion beta. |
Country Status (27)
| Country | Link |
|---|---|
| US (4) | US5922867A (en:Method) |
| EP (1) | EP0970074B1 (en:Method) |
| JP (1) | JP3229990B2 (en:Method) |
| KR (1) | KR100406159B1 (en:Method) |
| CN (1) | CN1080263C (en:Method) |
| AP (1) | AP879A (en:Method) |
| AT (1) | ATE214699T1 (en:Method) |
| AU (1) | AU706328B2 (en:Method) |
| BR (1) | BR9612351A (en:Method) |
| CA (1) | CA2237730C (en:Method) |
| DE (1) | DE69620042T2 (en:Method) |
| DK (1) | DK0970074T3 (en:Method) |
| EA (1) | EA000844B1 (en:Method) |
| ES (1) | ES2172697T3 (en:Method) |
| GB (1) | GB9525606D0 (en:Method) |
| HU (1) | HU224076B1 (en:Method) |
| IL (3) | IL124663A (en:Method) |
| IN (1) | IN187349B (en:Method) |
| MX (1) | MX9804701A (en:Method) |
| NO (1) | NO309901B1 (en:Method) |
| NZ (1) | NZ323855A (en:Method) |
| OA (1) | OA11094A (en:Method) |
| PL (1) | PL188447B1 (en:Method) |
| PT (1) | PT970074E (en:Method) |
| TW (1) | TW341574B (en:Method) |
| WO (1) | WO1997021706A1 (en:Method) |
| ZA (1) | ZA9610544B (en:Method) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0986375A2 (en) | 1997-04-07 | 2000-03-22 | Triangle Pharmaceuticals Inc. | Use of mkc-442 in combination with other antiviral agents |
| WO2000009494A1 (en) | 1998-08-12 | 2000-02-24 | Triangle Pharmaceuticals, Inc. | Method of manufacture of 1,3-oxathiolane nucleosides |
| US6979561B1 (en) | 1998-10-09 | 2005-12-27 | Gilead Sciences, Inc. | Non-homogeneous systems for the resolution of enantiomeric mixtures |
| JP2002533470A (ja) * | 1998-12-23 | 2002-10-08 | シャイアー・バイオケム・インコーポレイテッド | 抗ウイルス性ヌクレオシド類似体 |
| EP1151133A1 (en) * | 1999-02-11 | 2001-11-07 | McGILL UNIVERSITY | Stereoselective synthesis of nucleoside analogues |
| AU777869B2 (en) * | 1999-09-24 | 2004-11-04 | Shire Canada Inc. | Method for the treatment or prevention of viral infection using nucleoside analogues |
| US6566365B1 (en) | 1999-11-04 | 2003-05-20 | Biochem Pharma Inc. | Method for the treatment of Flaviviridea viral infection using nucleoside analogues |
| WO2001058920A2 (en) * | 2000-02-10 | 2001-08-16 | Mitsui Chemicals, Inc. | Process for selectively producing 1-phosphorylated sugar derivative anomer and process for producing nucleoside |
| ATE360016T1 (de) | 2000-02-11 | 2007-05-15 | Shire Biochem Inc | Ein stereoselektives verfahren zur herstellung von nukleosidanalogen |
| WO2002051852A1 (fr) * | 2000-12-27 | 2002-07-04 | Mitsui Chemicals, Inc. | Procede de production d'un derive de saccharide non naturel |
| ES2253544T3 (es) | 2001-03-01 | 2006-06-01 | Gilead Sciences, Inc. | Formas poliformicas y otras cristalinas de cis-ftc. |
| WO2003020222A2 (en) * | 2001-09-04 | 2003-03-13 | Merck & Co., Inc. | PYRROLO[2,3-d]PYRIMIDINES FOR INHIBITING RNA-DEPENDENT RNA VIRAL POLYMERASE |
| US6645972B2 (en) * | 2001-11-02 | 2003-11-11 | Shire Biochem Inc. | Methods of treating leukemia |
| WO2003063771A2 (en) * | 2001-12-14 | 2003-08-07 | Pharmasset Ltd. | N4-acylcytosine nucleosides for treatment of viral iinfections |
| CA2473736C (en) | 2002-01-25 | 2011-10-11 | Shire Biochem Inc. | Process for producing dioxolane nucleoside analogues |
| AU2003294212B2 (en) | 2002-08-06 | 2010-01-07 | Pharmasset Inc. | Processes for preparing 1,3-dioxolane nucleosides |
| JP4972284B2 (ja) | 2002-10-15 | 2012-07-11 | エクソンモービル・ケミカル・パテンツ・インク | オレフィン重合のための複数触媒系及びそれらから生成されたポリマー |
| DE10335061B4 (de) | 2003-07-31 | 2005-11-17 | Wacker-Chemie Gmbh | Verfahren zur Herstellung von OH-geschützten [4-(2,6-damino-9H-purin-9-yl)-1,3-dioxolan-2-yl]methanol-Derivaten |
| US7785839B2 (en) * | 2004-02-03 | 2010-08-31 | Emory University | Methods to manufacture 1,3-dioxolane nucleosides |
| US7749531B2 (en) * | 2005-06-08 | 2010-07-06 | Indicator Systems International | Apparatus and method for detecting bacterial growth beneath a wound dressing |
| BRPI0813036A2 (pt) * | 2007-07-30 | 2017-10-24 | Rfs Pharma Llc | processo estereosseletivo para preparar derivados do nucleosídeo dioxolana de purina. |
| CN101862676B (zh) * | 2009-04-17 | 2012-01-25 | 中国石油化工股份有限公司 | 大孔径sba-15介孔材料-三氟甲磺酸铜复合催化剂、制备方法及应用 |
| CN103288806A (zh) * | 2013-07-02 | 2013-09-11 | 山东大学 | 一种曲沙他滨的合成方法 |
| WO2018022263A1 (en) | 2016-07-29 | 2018-02-01 | Exxonmobil Chemical Patents Inc. | Polymerization processes using high molecular weight polyhydric quenching agents |
| JP7337539B2 (ja) * | 2018-06-21 | 2023-09-04 | メディヴィル・アクチエボラーグ | 白血病療法のための塩基修飾シチジンヌクレオチド |
| WO2019245444A1 (en) | 2018-06-21 | 2019-12-26 | Medivir Ab | Base-modified cytidine nucleotides for leukemia therapy |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5276151A (en) * | 1990-02-01 | 1994-01-04 | Emory University | Method of synthesis of 1,3-dioxolane nucleosides |
| HUT64359A (en) * | 1992-06-22 | 1993-12-28 | Lilly Co Eli | A stereoselective glycosyling procedure |
-
1995
- 1995-12-14 GB GBGB9525606.1A patent/GB9525606D0/en active Pending
-
1996
- 1996-12-13 CN CN96199879A patent/CN1080263C/zh not_active Expired - Lifetime
- 1996-12-13 PL PL96327443A patent/PL188447B1/pl not_active IP Right Cessation
- 1996-12-13 ES ES96941539T patent/ES2172697T3/es not_active Expired - Lifetime
- 1996-12-13 KR KR10-1998-0704473A patent/KR100406159B1/ko not_active Expired - Fee Related
- 1996-12-13 AT AT96941539T patent/ATE214699T1/de not_active IP Right Cessation
- 1996-12-13 CA CA002237730A patent/CA2237730C/en not_active Expired - Lifetime
- 1996-12-13 EP EP96941539A patent/EP0970074B1/en not_active Expired - Lifetime
- 1996-12-13 WO PCT/CA1996/000845 patent/WO1997021706A1/en active IP Right Grant
- 1996-12-13 HU HU9901050A patent/HU224076B1/hu active IP Right Grant
- 1996-12-13 AU AU10893/97A patent/AU706328B2/en not_active Expired
- 1996-12-13 US US08/849,722 patent/US5922867A/en not_active Expired - Lifetime
- 1996-12-13 EA EA199800555A patent/EA000844B1/ru not_active IP Right Cessation
- 1996-12-13 AP APAP/P/1998/001252A patent/AP879A/en active
- 1996-12-13 NZ NZ323855A patent/NZ323855A/xx unknown
- 1996-12-13 ZA ZA9610544A patent/ZA9610544B/xx unknown
- 1996-12-13 IL IL12466396A patent/IL124663A/en not_active IP Right Cessation
- 1996-12-13 BR BR9612351A patent/BR9612351A/pt not_active Application Discontinuation
- 1996-12-13 IN IN2810DE1996 patent/IN187349B/en unknown
- 1996-12-13 JP JP52157397A patent/JP3229990B2/ja not_active Expired - Lifetime
- 1996-12-13 IL IL14415596A patent/IL144155A/xx not_active IP Right Cessation
- 1996-12-13 PT PT96941539T patent/PT970074E/pt unknown
- 1996-12-13 TW TW085115392A patent/TW341574B/zh active
- 1996-12-13 DK DK96941539T patent/DK0970074T3/da active
- 1996-12-13 DE DE69620042T patent/DE69620042T2/de not_active Expired - Lifetime
-
1998
- 1998-06-09 OA OA9800077A patent/OA11094A/en unknown
- 1998-06-11 MX MX9804701A patent/MX9804701A/es unknown
- 1998-06-12 NO NO982716A patent/NO309901B1/no unknown
-
1999
- 1999-02-17 US US09/251,431 patent/US6069250A/en not_active Expired - Lifetime
-
2001
- 2001-07-05 IL IL14415501A patent/IL144155A0/xx unknown
- 2001-11-16 US US09/987,845 patent/US20020058670A1/en not_active Abandoned
-
2002
- 2002-10-02 US US10/262,107 patent/US20030060476A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2172697T3 (es) | Metodo y composiciones para la sintesis de nucleosidos de dioxolano que tienen una configuracion beta. | |
| KR890003790A (ko) | 에피포도필로톡신 배당체의 4'-포스페이트 유도체 | |
| DK0474672T3 (da) | Hidtil ukendt forbindelsesklasse med et variabelt aktivitetsspektrum af capsaicinlignende responser, præparater og anvendelser deraf | |
| ES2059377T3 (es) | Pirazoles 1,5-diaril-3-sustituidos farmacologicamente activos y procedimiento para sintetizar los mismos. | |
| PT96857A (pt) | Processo para a preparacao de oxetanonas | |
| BG96717A (bg) | Метод и състави за получаване на всн-189 и аналозите му | |
| ATE368660T1 (de) | Verfahren zur herstellung von enantiomerisch reine beta-d-dioxolan-nukleoside | |
| DK0594291T3 (da) | Fremgangsmåder til fremstilling af 13-etherderivater af milbemyciner og mellemprodukter dertil | |
| BR8800580A (pt) | Dionas ciclicas,processo para preparacao de compostos,composicoes e processo para controlar ervas daninhas | |
| FR2387231A1 (fr) | Derives hydrate de carbone de milbemycine, procedes de preparation et application comme agents antiparasitaires | |
| DE69938306D1 (de) | Pflanzen, samen und öle mit erhöhtem gesamtgehalt an einfachgesättigten fettsäuren | |
| MA22932A1 (fr) | Procede de preparation de compositions detergentes de densite apparente elevee et composition obtenue par ce procede. | |
| BR9302029A (pt) | Metodo para produzir uma composicao,metodo para produzir uma solucao aquosa,composicao,e,processo para retardar o crescimento microbial | |
| FI943366L (fi) | Menetelmä kasvien käsittelemiseksi siementen laatuominaisuuksien parantamiseksi | |
| DE3585109D1 (de) | Verfahren zur herstellung von (+/-)-3a,6,6,9a-tetramethylperhydronaphtho(2,1-b)furan. | |
| ES2037763T3 (es) | Metodo para preparar compuestos no naturales afines a la ceramida. | |
| MX9200487A (es) | Metodo para mejorar las caracteristicas de suelos portadores de sulfato. | |
| FR2666095B1 (fr) | Production de la l-lysine par fermentation. | |
| DE69232259D1 (de) | Verfahren zur Herstellung von Interleukin-6 Zusammensetzungen | |
| ES2106800T3 (es) | Composicion que contiene gamma octalactona, procedimiento de fermentacion para su produccion y usos organolepticos de la misma. | |
| DE3582371D1 (de) | Oxindolverbindungen, diese enthaltende zusammensetzungen sowie verfahren zur herstellung derselben. | |
| ATE124947T1 (de) | Verfahren zur herstellung substituierter cyclobutane. | |
| ES2061712T3 (es) | Nuevos derivados sustituidos de 20,21-dinoreburnamenina, su procedimiento de preparacion y los nuevos productos intermedios asi obtenidos, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen. | |
| HUP9702365A3 (en) | Application of hydroxilamin-derivatives, as well as process and composition for increase of weather extreme resistent by cultivated plants | |
| DK0817784T3 (da) | Fremgangsmåde til syntese af nucleosidanaloger |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 970074 Country of ref document: ES |